Integrated Advisors Network’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-9,792
Closed -$5.5M 720
2026
Q1
$5.5M Buy
9,792
+9,454
+2,797% +$6.06M 0.29% 88
2025
Q4
$229K Sell
338
-138
-29% -$94K 0.01% 660
2025
Q3
$304K Buy
476
+96
+25% +$58.3K 0.01% 626
2025
Q2
$204K Buy
+380
New +$182K 0.01% 716

Other funds holding IDXX

Integrated Advisors Network's IDXX Position: Q2 2026 in Review

Integrated Advisors Network sold out of Idexx Laboratories (IDXX) in Q2 2026, closing a stake of 9,792 shares — an estimated $5.5M sold.

Integrated Advisors Network first reported a position in IDXX in Q2 2025 and held it in 4 quarters. The position peaked at $5.5M in Q1 2026. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Integrated Advisors Network reported no remaining Idexx Laboratories position as of Q2 2026 after selling out during the quarter.
  • Integrated Advisors Network sold 9,792 Idexx Laboratories shares in Q2 2026, an estimated $5.5M.
  • Integrated Advisors Network first reported a position in Idexx Laboratories in Q2 2025 and held it in 4 quarters.
  • Integrated Advisors Network's Idexx Laboratories position peaked at $5.5M in Q1 2026.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Integrated Advisors Network's 13F filing for Q2 2026, filed 11 Aug 2026.